Hoffman-La Roche Herceptin Product Recall (2020-06-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs, Biologic/vaccine
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. Perjeta-Herceptin Kit Powder for solution (Combo pack); B. Herceptin 440 mg/vial powder for solution
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| N3928B01 | - Recalling Firm
- Hoffmann-La Roche Limited
- 7070 Mississauga Road
- Mississauga
- L5N 5M8
- Ontario
- CANADA
- Marketing Authorization Holder
- Hoffmann-La Roche Limited
- 7070 Mississauga Road
- Mississauga
- L5N 5M8
- Ontario
- CANADA
| B. Herceptin 440 mg/vial powder for solution | DIN 02240692 | Powder for solution | Trastuzumab 440 mg/vial |
| H0379B19 | - Recalling Firm
- Hoffmann-La Roche Limited
- 7070 Mississauga Road
- Mississauga
- L5N 5M8
- Ontario
- CANADA
- Marketing Authorization Holder
- Hoffmann-La Roche Limited
- 7070 Mississauga Road
- Mississauga
- L5N 5M8
- Ontario
- CANADA
| A. Perjeta-Herceptin Kit Powder for solution (Combo pack) | DIN 02405024 | Kit, Powder For Solution, Solution | Pertuzumab 420 mg/14 mL |
Affected lots may contain the presence of glass particulates.
Wholesalers, Healthcare establishments